Sarepta Therapeutics Statistics
Total Valuation
SRPT has a market cap or net worth of $1.78 billion. The enterprise value is $2.34 billion.
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
Earnings Date | Aug 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SRPT has 98.28 million shares outstanding. The number of shares has decreased by -0.99% in one year.
Current Share Class | 98.28M |
Shares Outstanding | 98.28M |
Shares Change (YoY) | -0.99% |
Shares Change (QoQ) | +9.51% |
Owned by Insiders (%) | 4.43% |
Owned by Institutions (%) | 80.84% |
Float | 88.78M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 9.38 |
PS Ratio | 0.70 |
Forward PS | 1.15 |
PB Ratio | 1.30 |
P/TBV Ratio | 1.34 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.94 |
EV / EBITDA | 58.29 |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.89, with a Debt / Equity ratio of 1.01.
Current Ratio | 2.89 |
Quick Ratio | 1.53 |
Debt / Equity | 1.01 |
Debt / EBITDA | 8.45 |
Debt / FCF | n/a |
Interest Coverage | -0.05 |
Financial Efficiency
Return on equity (ROE) is -4.76% and return on invested capital (ROIC) is -0.02%.
Return on Equity (ROE) | -4.76% |
Return on Assets (ROA) | -0.02% |
Return on Invested Capital (ROIC) | -0.02% |
Return on Capital Employed (ROCE) | -0.03% |
Revenue Per Employee | $1.81M |
Profits Per Employee | -$42,242 |
Employee Count | 1,372 |
Asset Turnover | 0.70 |
Inventory Turnover | 2.59 |
Taxes
In the past 12 months, SRPT has paid $33.83 million in taxes.
Income Tax | 33.83M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.13% in the last 52 weeks. The beta is 0.45, so SRPT's price volatility has been lower than the market average.
Beta (5Y) | 0.45 |
52-Week Price Change | -87.13% |
50-Day Moving Average | 17.88 |
200-Day Moving Average | 70.78 |
Relative Strength Index (RSI) | 45.90 |
Average Volume (20 Days) | 10,497,212 |
Short Selling Information
The latest short interest is 18.24 million, so 18.56% of the outstanding shares have been sold short.
Short Interest | 18.24M |
Short Previous Month | 20.95M |
Short % of Shares Out | 18.56% |
Short % of Float | 20.55% |
Short Ratio (days to cover) | 0.87 |
Income Statement
In the last 12 months, SRPT had revenue of $2.48 billion and -$57.96 million in losses. Loss per share was -$0.60.
Revenue | 2.48B |
Gross Profit | 565.14M |
Operating Income | -932,000 |
Pretax Income | 62.22M |
Net Income | -57.96M |
EBITDA | 40.15M |
EBIT | -932,000 |
Loss Per Share | -$0.60 |
Full Income Statement Balance Sheet
The company has $800.14 million in cash and $1.36 billion in debt, giving a net cash position of -$564.15 million or -$5.74 per share.
Cash & Cash Equivalents | 800.14M |
Total Debt | 1.36B |
Net Cash | -564.15M |
Net Cash Per Share | -$5.74 |
Equity (Book Value) | 1.36B |
Book Value Per Share | 13.89 |
Working Capital | 1.74B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$300.75 million and capital expenditures -$150.79 million, giving a free cash flow of -$451.55 million.
Operating Cash Flow | -300.75M |
Capital Expenditures | -150.79M |
Free Cash Flow | -451.55M |
FCF Per Share | -$4.59 |
Full Cash Flow Statement Margins
Gross margin is 22.77%, with operating and profit margins of -0.04% and -2.34%.
Gross Margin | 22.77% |
Operating Margin | -0.04% |
Pretax Margin | -0.97% |
Profit Margin | -2.34% |
EBITDA Margin | 1.62% |
EBIT Margin | -0.04% |
FCF Margin | n/a |
Dividends & Yields
SRPT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.99% |
Shareholder Yield | 0.99% |
Earnings Yield | -3.26% |
FCF Yield | -25.43% |
Dividend Details Analyst Forecast
The average price target for SRPT is $44.37, which is 145.55% higher than the current price. The consensus rating is "Hold".
Price Target | $44.37 |
Price Target Difference | 145.55% |
Analyst Consensus | Hold |
Analyst Count | 30 |
Revenue Growth Forecast (5Y) | -6.24% |
EPS Growth Forecast (5Y) | 0.31% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on July 12, 2012. It was a reverse split with a ratio of 1:6.
Last Split Date | Jul 12, 2012 |
Split Type | Reverse |
Split Ratio | 1:6 |
Scores
SRPT has an Altman Z-Score of 2.08 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.08 |
Piotroski F-Score | 1 |